title: CSF sTREM2: marking the tipping point between preclinical AD and dementia?
authors.affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: Suzanne E
authors.initials: SE
authors.lastname: Schindler
authors.affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: David M
authors.initials: DM
authors.lastname: Holtzman
mesh_terms: D000544:Alzheimer Disease; D016229:Amyloid beta-Peptides; D015415:Biomarkers; D003704:Dementia; D006801:Humans; D010446:Peptide Fragments; D016875:tau Proteins
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers; D010446:Peptide Fragments; D016875:tau Proteins